• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by PetVivo Holdings Inc.

    7/28/25 10:47:08 AM ET
    $PETV
    Medical/Dental Instruments
    Health Care
    Get the next $PETV alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 21)


    PetVivo Holdings, Inc.

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    716817408

    (CUSIP Number)


    06/30/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    716817408


    1Names of Reporting Persons

    CRUDEN STANLEY C
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    FLORIDA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    2,441,920.00
    6Shared Voting Power

    7Sole Dispositive Power

    2,441,920.00
    8Shared Dispositive Power

    9Aggregate Amount Beneficially Owned by Each Reporting Person

    2,441,920.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    10.0 %
    12Type of Reporting Person (See Instructions)

    IN


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    PetVivo Holdings, Inc.
    (b)Address of issuer's principal executive offices:

    5251 EDINA INDUSTRIAL BLVD, 5251 EDINA INDUSTRIAL BLVD, EDINA, MINNESOTA, 55439.

    Item 10.Certifications:
     

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    CRUDEN STANLEY C
     
    Signature:Stanley C. Cruden
    Name/Title:Individual
    Date:07/28/2025
    Get the next $PETV alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PETV

    DatePrice TargetRatingAnalyst
    10/12/2021$7.00Buy
    ThinkEquity
    More analyst ratings

    $PETV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Lowenthal Garry N was granted 75,000 shares (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    10/30/25 6:13:27 AM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    Chief Executive Officer Lai John was granted 75,000 shares (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    10/30/25 6:07:05 AM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    Director Levitan Diane M was granted 12,500 shares, increasing direct ownership by 28% to 56,489 units (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    10/17/25 3:06:23 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    $PETV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PetVivo Reports Fiscal Q2 2026 Results with Revenues up 50%

    MINNEAPOLIS, MN, US, Nov. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTC ID: PETVW)), through its wholly owned subsidiary Petvivo Animal Health, a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, reported results for its second quarter and first half of fiscal year 2026 ended September 30, 2025. All comparisons are to the same year-ago period unless otherwise noted. The company will hold a conference call today at 5:00 p.m. Eastern time to discuss the results for the quarter, followed by a question-and-answer session (see dial-in information below). Fiscal Q2 Financial Highlights Revenues totaled

    11/14/25 4:30:00 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    PetVivo Sets Fiscal Second Quarter 2026 Conference Call for Friday, November 14, 2025 at 5:00 p.m. ET

    MINNEAPOLIS, MN, US, Nov. 07, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTCID: PETVW)) and its wholly-owned subsidiary Petvivo Animal Health, Inc., a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Friday, November 14, 2025 at 5:00 p.m. Eastern time to discuss results for the fiscal second quarter ended September 30, 2025. The financial results will be issued in a press release prior to the call. PetVivo management will host the presentation, followed by a question-and-answer period. The Fiscal Second Quarter 2026 conference call information is as follows: Date: Friday,

    11/7/25 1:18:54 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    Josh Ruben Joins PetVivo Holdings, Inc. Board of Directors

    MINNEAPOLIS, MN, US, Oct. 28, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTCID PETVW)), in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc., both emerging biomedical device companies focused on the commercialization of innovative medical therapeutics for companion animals and animal athletes is pleased to announce that Josh Ruben has joined the Company's Board of Directors. "We are honored to welcome Josh Ruben to our Board of Directors," said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. "Josh brings a wealth of experience in healthcare finance, capital markets, and corporate strategy, with a proven track record of executing multi-b

    10/28/25 8:00:00 AM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    $PETV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    ThinkEquity initiated coverage on PetVivo Holdings with a new price target

    ThinkEquity initiated coverage of PetVivo Holdings with a rating of Buy and set a new price target of $7.00

    10/12/21 11:03:37 AM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    $PETV
    SEC Filings

    View All

    SEC Form 10-Q filed by PetVivo Holdings Inc.

    10-Q - PetVivo Holdings, Inc. (0001512922) (Filer)

    11/14/25 4:00:59 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    PetVivo Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - PetVivo Holdings, Inc. (0001512922) (Filer)

    11/3/25 2:18:14 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    PetVivo Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - PetVivo Holdings, Inc. (0001512922) (Filer)

    10/30/25 3:24:52 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    $PETV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Lai John bought $90,000 worth of shares (150,000 units at $0.60), increasing direct ownership by 13% to 1,288,592 units (SEC Form 4)

    4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

    4/17/24 5:28:07 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    $PETV
    Leadership Updates

    Live Leadership Updates

    View All

    Josh Ruben Joins PetVivo Holdings, Inc. Board of Directors

    MINNEAPOLIS, MN, US, Oct. 28, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTCID PETVW)), in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc., both emerging biomedical device companies focused on the commercialization of innovative medical therapeutics for companion animals and animal athletes is pleased to announce that Josh Ruben has joined the Company's Board of Directors. "We are honored to welcome Josh Ruben to our Board of Directors," said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. "Josh brings a wealth of experience in healthcare finance, capital markets, and corporate strategy, with a proven track record of executing multi-b

    10/28/25 8:00:00 AM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    PetVivo and Commonwealth Partner to Advance Equine Wellness Across Thoroughbred Racing

    Minneapolis, MN, June 06, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW), an emerging biomedical device company focused on animal health, today announced a strategic collaboration with Commonwealth, the syndicated ownership group behind 2023 Kentucky Derby winner Mage, and 2022 Dubai World Cup Champion Country Grammer. The partnership centers on the clinical use and promotion of SPRYNG® with OsteoCushion® Technology, PetVivo's cutting-edge intra-articular device designed to support joint health and durability, and Precise PRP™, a first-in-class off-the-shelf platelet-rich plasma (PRP) product designed for use by veterinarians in elite equine athletes. As part of t

    6/6/25 8:00:00 AM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor

    PetVivo Board Appoints Eldred as Executive Director to Lead Company Product Commercialization and Operations MINNEAPOLIS, MN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, PETVW)), a leading provider of biomedical therapeutics for equines and companion animals, has appointed Mike Eldred as the Company's Commercialization and Operations Advisor. His appointment as an Executive Director by the Company's Board of Directors draws upon Mr. Eldred's 30 years of executive experience in animal health and the veterinary industry to ramp up its product development and sales efforts. For the past 20 years, Mr. Eldred served as President of North American Operations for Dech

    1/27/25 9:29:00 AM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    $PETV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by PetVivo Holdings Inc.

    SC 13G/A - PetVivo Holdings, Inc. (0001512922) (Subject)

    11/19/24 3:38:53 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by PetVivo Holdings Inc.

    SC 13G - PetVivo Holdings, Inc. (0001512922) (Subject)

    11/4/24 1:57:37 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by PetVivo Holdings Inc.

    SC 13G/A - PetVivo Holdings, Inc. (0001512922) (Subject)

    10/1/24 5:26:09 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    $PETV
    Financials

    Live finance-specific insights

    View All

    PetVivo Reports Fiscal Q2 2026 Results with Revenues up 50%

    MINNEAPOLIS, MN, US, Nov. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTC ID: PETVW)), through its wholly owned subsidiary Petvivo Animal Health, a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, reported results for its second quarter and first half of fiscal year 2026 ended September 30, 2025. All comparisons are to the same year-ago period unless otherwise noted. The company will hold a conference call today at 5:00 p.m. Eastern time to discuss the results for the quarter, followed by a question-and-answer session (see dial-in information below). Fiscal Q2 Financial Highlights Revenues totaled

    11/14/25 4:30:00 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    PetVivo Sets Fiscal Second Quarter 2026 Conference Call for Friday, November 14, 2025 at 5:00 p.m. ET

    MINNEAPOLIS, MN, US, Nov. 07, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX:PETV, OTCID: PETVW)) and its wholly-owned subsidiary Petvivo Animal Health, Inc., a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, will hold a conference call on Friday, November 14, 2025 at 5:00 p.m. Eastern time to discuss results for the fiscal second quarter ended September 30, 2025. The financial results will be issued in a press release prior to the call. PetVivo management will host the presentation, followed by a question-and-answer period. The Fiscal Second Quarter 2026 conference call information is as follows: Date: Friday,

    11/7/25 1:18:54 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care

    PetVivo Reports Fiscal Q1 2026 Results

    MINNEAPOLIS, MN, US, Aug. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc., including its wholly-owned subsidiary Petvivo Animal Health, Inc. (OTCQX:PETV, OTC ID: PETVW)), a leading biomedical company delivering innovative medical devices and therapeutics for equines and companion animals, reported results for its first quarter of fiscal year 2026 ended June 30, 2025. All comparisons are to the previous year first quarter period ending June 30, 2024, unless otherwise noted. The company will hold a conference call today, August 14, 2025, at 5:00 p.m. Eastern time to discuss the results for the quarter, followed by a question-and-answer session (see dial-in information below). Fiscal Q1

    8/14/25 4:40:00 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care